Aptose Biosciences Files 8-K
Ticker: APTOF · Form: 8-K · Filed: Apr 23, 2025 · CIK: 882361
Sentiment: neutral
Topics: disclosure, financials
Related Tickers: APTO
TL;DR
APTO filed an 8-K, standard disclosure stuff, no major news.
AI Summary
Aptose Biosciences Inc. filed an 8-K on April 23, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc., is incorporated in Canada and has its principal executive offices in Toronto. This filing does not contain specific financial figures or material events beyond the reporting of these items.
Why It Matters
This 8-K filing indicates Aptose Biosciences Inc. is providing required disclosures and financial updates to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any specific new risks or material events.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- Lorus Therapeutics Inc. (company) — Former company name
- Imutec Pharma Inc (company) — Former company name
- April 23, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Aptose Biosciences Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is April 23, 2025.
What are the former names of Aptose Biosciences Inc. mentioned in the filing?
The former names of Aptose Biosciences Inc. mentioned are Lorus Therapeutics Inc. and Imutec Pharma Inc.
In which jurisdiction is Aptose Biosciences Inc. incorporated?
Aptose Biosciences Inc. is incorporated in Canada.
What is the SIC code and industry classification for Aptose Biosciences Inc.?
The SIC code is 2836 and the industry classification is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Aptose Biosciences Inc. (APTOF).